PDS Biotechnology Statistics

Total Valuation

PDSB has a market cap or net worth of $61.73 million. The enterprise value is $36.64 million.

Market Cap	61.73M
Enterprise Value	36.64M

Important Dates

The last earnings date was Thursday, November 14, 2024, before market open.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

PDSB has 37.41 million shares outstanding. The number of shares has increased by 15.51% in one year.

Current Share Class	37.41M
Shares Outstanding	37.41M
Shares Change (YoY)	+15.51%
Shares Change (QoQ)	+0.31%
Owned by Insiders (%)	3.70%
Owned by Institutions (%)	12.34%
Float	36.02M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.76
P/TBV Ratio	2.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.84, with a Debt / Equity ratio of 1.12.

Current Ratio	2.84
Quick Ratio	2.71
Debt / Equity	1.12
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-8.28

Financial Efficiency

Return on equity (ROE) is -174.49% and return on invested capital (ROIC) is -51.93%.

Return on Equity (ROE)	-174.49%
Return on Assets (ROA)	-44.88%
Return on Capital (ROIC)	-51.93%
Revenue Per Employee	n/a
Profits Per Employee	-$1.62M
Employee Count	25
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-869,167
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -67.71% in the last 52 weeks. The beta is 1.84, so PDSB's price volatility has been higher than the market average.

Beta (5Y)	1.84
52-Week Price Change	-67.71%
50-Day Moving Average	2.60
200-Day Moving Average	3.22
Relative Strength Index (RSI)	29.12
Average Volume (20 Days)	391,673

Short Selling Information

The latest short interest is 3.88 million, so 10.37% of the outstanding shares have been sold short.

Short Interest	3.88M
Short Previous Month	3.87M
Short % of Shares Out	10.37%
Short % of Float	10.77%
Short Ratio (days to cover)	10.47

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-39.37M
Pretax Income	-45.29M
Net Income	-40.56M
EBITDA	-39.31M
EBIT	-39.37M
Earnings Per Share (EPS)	-$1.16

Full Income Statement

Balance Sheet

The company has $49.75 million in cash and $24.67 million in debt, giving a net cash position of $25.08 million or $0.67 per share.

Cash & Cash Equivalents	49.75M
Total Debt	24.67M
Net Cash	25.08M
Net Cash Per Share	$0.67
Equity (Book Value)	22.00M
Book Value Per Share	0.60
Working Capital	33.79M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$35.25 million and capital expenditures -$29,000, giving a free cash flow of -$35.28 million.

Operating Cash Flow	-35.25M
Capital Expenditures	-29,000
Free Cash Flow	-35.28M
FCF Per Share	-$0.94

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PDSB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.51%
Shareholder Yield	-15.51%
Earnings Yield	-65.70%
FCF Yield	-57.16%

Analyst Forecast

The average price target for PDSB is $14.00, which is 748.49% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.00
Price Target Difference	748.49%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on March 18, 2019. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Mar 18, 2019
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2